112 related articles for article (PubMed ID: 6441765)
1. Lithium and lecithin treatment in Alzheimer's disease: a pilot study.
Randels PM; Marco LA; Ford DI; Mitchell R; Scholl M; Plesnarski J
Hillside J Clin Psychiatry; 1984; 6(2):139-47. PubMed ID: 6441765
[TBL] [Abstract][Full Text] [Related]
2. Lithium-induced accentuation of extrapyramidal symptoms in individuals with Alzheimer's disease.
Kelwala S; Pomara N; Stanley M; Sitaram N; Gershon S
J Clin Psychiatry; 1984 Aug; 45(8):342-4. PubMed ID: 6430878
[TBL] [Abstract][Full Text] [Related]
3. Possible lithium-induced extrapyramidal effects in Alzheimer's disease.
Randels PM; Marco LA; Hanspal NS; Robinson B
Hillside J Clin Psychiatry; 1984; 6(1):117-21. PubMed ID: 6571454
[TBL] [Abstract][Full Text] [Related]
4. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
[TBL] [Abstract][Full Text] [Related]
5. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
Smith RC; Vroulis G; Johnson R; Morgan R
Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
[No Abstract] [Full Text] [Related]
6. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
7. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
[TBL] [Abstract][Full Text] [Related]
9. A case of lithium-chlorpromazine interaction.
Yassa R
J Clin Psychiatry; 1986 Feb; 47(2):90-1. PubMed ID: 3080413
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease.
Tan RS; Pu SJ
Aging Male; 2003 Mar; 6(1):13-7. PubMed ID: 12809076
[TBL] [Abstract][Full Text] [Related]
11. Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease.
Clipp EC; Moore MJ
Clin Pharmacol Ther; 1995 Aug; 58(2):228-36. PubMed ID: 7648773
[TBL] [Abstract][Full Text] [Related]
12. NGF and the treatment of Alzheimer's disease.
Olson L
Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Antuono PG
Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
[TBL] [Abstract][Full Text] [Related]
14. Maximizing function in Alzheimer's disease: what role for tacrine?
Smucker WD
Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
[TBL] [Abstract][Full Text] [Related]
16. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
Chu LW; Yik PY; Mok W; Chung CP
Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors.
Bianchetti A; Rozzini R; Trabucchi M
Curr Med Res Opin; 2003; 19(4):350-3. PubMed ID: 12841930
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
Cummings JL; Mendez MF
Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
[TBL] [Abstract][Full Text] [Related]
20. Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia.
Brinkman SD; Pomara N; Barnett N; Block R; Domino EF; Gershon S
Biol Psychiatry; 1984 Feb; 19(2):157-64. PubMed ID: 6424733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
